CLINICIAN'S CORNER
Postmenopausal Estrogen for Treatment of Hot Flashes
Clinical Applications
Heidi D. Nelson, MD, MPH
JAMA. 2004;291:1621-1625.
Use of postmenopausal estrogen has changed since the release of the first results from the Women's Health Initiative in 2002. Professional organizations, the US Food and Drug Administration, and the US Preventive Services Task Force have issued new recommendations against use of estrogen and progestin or progesterone for prevention of chronic conditions. This article applies the current state of evidence for postmenopausal estrogen use to management decisions in 2 clinical scenarios initiating therapy in a perimenopausal woman with hot flashes and discontinuing estrogen use in a long-term user.
Author Affiliations: Oregon Evidence-based Practice Center, Department of Medical Informatics and Clinical Epidemiology, and Department of Medicine, Oregon Health and Science University, Portland.
RELATED ARTICLE
Commonly Used Types of Postmenopausal Estrogen for Treatment of Hot Flashes: Scientific Review
Heidi D. Nelson
JAMA. 2004;291(13):1610-1620.
ABSTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Lipoprotein(a), Hormone Replacement Therapy, and Risk of Future Cardiovascular Events
Suk Danik et al.
J Am Coll Cardiol 2008;52:124-131.
ABSTRACT
| FULL TEXT
Lifetime Weight History and Endometrial Cancer Risk by Type of Menopausal Hormone Use in the NIH-AARP Diet and Health Study
Chang et al.
Cancer Epidemiol. Biomarkers Prev. 2007;16:723-730.
ABSTRACT
| FULL TEXT
Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health-AARP Diet and Health Study Cohort.
Lacey et al.
JNCI J Natl Cancer Inst 2006;98:1397-1405.
ABSTRACT
| FULL TEXT
The Impact of Hormone Replacement Therapy on Menopausal Symptoms in Younger High-Risk Women After Prophylactic Salpingo-Oophorectomy
Madalinska et al.
JCO 2006;24:3576-3582.
ABSTRACT
| FULL TEXT
|
